HAc40 is a novel microbiome modulator, effective on atopic dermatitis in children: data from two pilot vehicle‐controlled trials

Abstract

Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases.1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of S. aureus colonization and secondary infections.2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged4 and several attempts have been conducted to restore a microbiome balance through skin bacteria replacement.5.